BLRX BioLineRX Ltd. ADRs

BioLine Rx Ltd is a clinical stage biopharmaceutical development company engaged in identifying, in-licensing & developing therapeutic compounds. This is an ADR of a company whose stock trades outside of the U.S. as the symbol IT:BLRX.

$2.25  -0.08 (-3.23%)
As of 12/03/2021 15:59:06 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  Israel
IPO date:  07/25/2011
Outstanding shares:  47,462,227
Average volume:  382,506
Market cap:   $110,112,367
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    09071M106
ISIN:        US09071M1062
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.48
PS ratio:   0.00
Return on equity:   -49.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy